Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Analogues of BD-1008 possess functional sigma receptor antagonism and anticocaine effects

March 12, 2001

Mayo Clinic presents data on new aldehyde dehydrogenase inhibitor at ASCPT meeting

March 8, 2001

CeNeS cleared to commence clinical trial of treatment for alcohol addiction

March 2, 2001

Chelating drug to be codeveloped by Biomedical Frontiers and Chiesii

March 2, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

CroFab now available in the U.S. for treatment of poisonous snakebites

Feb. 1, 2001

Anticocaine catalytic MAb selectively attenuates cocaine selfadministration in rats

Jan. 9, 2001

FDA approves second indication for Antizol

Dec. 13, 2000

Antizol approved in Canada for treatment of ethylene glycol poisoning

Dec. 6, 2000

Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...